A combination of the anti-CTLA-4 immunotherapeutic ipilimumab (Yervoy) and the anti-PD-1 immunotherapeutic nivolumab (Opdivo) showed clinical benefit among patients with rare, high-grade neuroendocrine carcinoma, according ...
Mar 31, 2019
0
3
A large clinical trial involving people with acute kidney injury has found that a new package of interventions can significantly improve the diagnosis and treatment of patients, as well as improving their care experience.
Feb 21, 2019
0
0
Vaccination with the new recombinant zoster vaccine (RZV) provides greater protection against shingles and is cost-effective compared with zoster vaccine live (ZVL) or no vaccination. Findings from a cost-effectiveness study ...
Feb 19, 2019
0
1
The human body is constantly exposed to so-called free radicals, which are a burden on the body. If they get out of hand, the result is oxidative stress, which can promote disease. While this has been treated in the past ...
Jan 15, 2019
0
1
(HealthDay)—A large, new analysis helps confirm that eating lots of grains, vegetables and fruit lowers your risk of dying early from cancer or heart disease.
Jan 11, 2019
0
1
Researchers are investigating the clinical benefits and cost effectiveness of a specially-adapted yoga programme for older people with multiple long-term health conditions.
Nov 29, 2018
0
11
There is a movement afoot (pun intended) to get more people exercising by involving their family doctors.
Nov 16, 2018
0
17
Treatment with a HER2-targeted therapeutic cancer vaccine provided clinical benefit to several patients with metastatic HER2-positive cancers who had not previously been treated with a HER2-targeted therapeutic, according ...
Sep 30, 2018
0
1
ESMO, the leading professional organisation for medical oncology, shares concerns expressed in a scientific paper and reflected in the international media about the rising costs of cancer medicines.
Apr 26, 2018
0
2
Spending on cancer drugs in the United States has nearly doubled in the past five years and continues to grow, imposing substantial financial burden on patients with cancer. One of the biggest drivers of this growth is targeted ...
Apr 18, 2018
0
2
